In-vitro susceptibility of 248 isolates of Candida sp. and Cryptococcus neoformans to four antifungal agents

龙丰,张永信,李民,章强强,王家俊

DOI: https://doi.org/10.3969/j.issn.1001-8689.2002.05.014

2002-01-01

Abstract:To evaluate the susceptibility of Cryptococcus noeformans and Candida sp. to fluconazole, amphotericin B, 5-flucytosine and ketoconazole. The MICs (minimal of inhibition concentrations) of 188 Candida sp. isolates and 60 Cryptococcus neoformans isolates to four antifungal agents were tested by microdilution broth method according to the NCCLS M27-A microdilution method. The MIC and susceptible rate of 160 Candida albicans isolates to four antifungal agents were as follows: fluconazole 0.125 ∼ ≥64μg/ml, 84.38% susceptible, 6.25 % intermediate, 9.37% resistant; 5-flucytosine 0.125 ∼ 32μg/ml, 97.5% susceptible, 1.25% intermediate, 1.25% resistant; amphotericin B 0.06 ∼ 4kμ/ml; ketoconazole 0.03 ∼ 32μg/ml. The MIC and susceptibility of 60 isolates of Cryptococcus neoformans to four agents were as follows: fluconazole 1 ∼ >64μg/ml, 58.4% susceptible, 33.3% intermediate, 8.3% resistant; 5-flucytosine MIC 0.25 ∼ 8μg/ml, 88.3 % susceptible, 11.7% intermediate; amphotericin B 0.03 ∼ 1 μg/ml, 100% susceptible; ketoconazole 0.125 ∼ 1μg/ml 100% susceptible. The resistant rates of Candida tropicalis and Candida glabrata to fluconazole were 10% and 22.2% respectively. Conclusion Candida sp. and Cryptococcus neoformans isolates revealed some degree of resistance to fluconazole, ketoconzole, amphotericin B and 5-flucytocine.